Rosiglitazone Does Not Show Major Hidden Cardiotoxicity in Models of Ischemia/Reperfusion but Abolishes Ischemic Preconditioning-Induced Antiarrhythmic Effects in Rats In Vivo

Clinical observations are highly inconsistent with the use of the antidiabetic rosiglitazone regarding its associated increased risk of myocardial infarction. This may be due to its hidden cardiotoxic properties that have only become evident during post-marketing studies. Therefore, we aimed to inve...

Full description

Saved in:
Bibliographic Details
Main Authors: Bennet Y. Weber (Author), Gábor B. Brenner (Author), Bernadett Kiss (Author), Tamás G. Gergely (Author), Nabil V. Sayour (Author), Huimin Tian (Author), András Makkos (Author), Anikó Görbe (Author), Péter Ferdinandy (Author), Zoltán Giricz (Author)
Format: Book
Published: MDPI AG, 2022-08-01T00:00:00Z.
Subjects:
Online Access:Connect to this object online.
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

Connect to this object online.

3rd Floor Main Library

Holdings details from 3rd Floor Main Library
Call Number: A1234.567
Copy 1 Available